You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 4, April 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Skin Cancer
 •Dermatology
 •Dermatologic Disorders
 •Neoplasms
 •Papillomavirus, Human
 •Immunotherapy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Successful Treatment of Invasive Squamous Cell Carcinoma Using Topical Imiquimod

Ulrich R. Hengge, MD; Jörg Schaller, MD
From the Heinrich-Heine-University, Duesseldorf (Dr Hengge), and St Barbara Hospital, Duisburg (Dr Schaller), Germany.

Arch Dermatol. 2004;140:404-406.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

A 65-year-old man with a history of renal transplantation, chronic renal insufficiency after graft failure, and hemodialysis presented with a red palpable lesion on his right temple that had developed over a 3-year period (Figure 1A). The 4 x 3-cm erythematous hyperkeratotic plaque was located at the hair rim. On palpation, some induration and several papules were noted. Histologic examination of a 5-mm punch biopsy specimen showed tumor cells with variably irregular nuclei and several atypic mitoses that extended into the dermis (Figure 2A).


 
Figure appears in full text version.
Figure 1. A, Erythematous, hyperkeratotic plaque (4 x 3 cm) of 3 year's duration on the right temporal aspect of the hair rim. B, At week 4, initial regression is evident at the borders, while the central erythema persists. C, At week 16, a scar is seen at the lesion site.



 
Figure appears in full text version.
Figure 2. A, At . . . [Full Text of this Article]


THERAPEUTIC CHALLENGE

COMMENT



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lentigo maligna and radiotherapy.
Wilson and Noel
NEJM 2006;354:1322-1322.
FULL TEXT  

Safety and Efficacy of 5% Imiquimod Cream for the Treatment of Skin Dysplasia in High-Risk Renal Transplant Recipients: Randomized, Double-blind, Placebo-Controlled Trial
Brown et al.
Arch Dermatol 2005;141:985-993.
ABSTRACT | FULL TEXT  

Imiquimod and Squamous Cell Cancer
Hengge and Schaller
Arch Dermatol 2005;141:787-788.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.